Ross L. Levine

93.5k total citations · 14 hit papers
501 papers, 33.9k citations indexed

About

Ross L. Levine is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Ross L. Levine has authored 501 papers receiving a total of 33.9k indexed citations (citations by other indexed papers that have themselves been cited), including 293 papers in Hematology, 217 papers in Genetics and 210 papers in Molecular Biology. Recurrent topics in Ross L. Levine's work include Acute Myeloid Leukemia Research (223 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (188 papers) and Chronic Myeloid Leukemia Treatments (85 papers). Ross L. Levine is often cited by papers focused on Acute Myeloid Leukemia Research (223 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (188 papers) and Chronic Myeloid Leukemia Treatments (85 papers). Ross L. Levine collaborates with scholars based in United States, Germany and Canada. Ross L. Levine's co-authors include Omar Abdel‐Wahab, D. Gary Gilliland, Benjamin L. Ebert, Ayalew Tefferi, Patrick S. Ward, Craig B. Thompson, Alan H. Shih, Animesh Pardanani, Ari Melnick and Hagop M. Kantarjian and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Ross L. Levine

484 papers receiving 33.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate

2010 1.5k citations Patrick S. Ward, Jay Patel et al. profile →
IDH mutation impairs histone demethylation and results in a block to cell differentiation

2012 1.5k citations Patrick S. Ward, Omar Abdel‐Wahab et al. profile →
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype

2012 1.4k citations Patrick S. Ward, Craig B. Thompson et al. profile →
Clinical Effect of Point Mutations in Myelodysplastic Syndromes

2011 1.1k citations Rafael Bejar, Kristen E. Stevenson et al. profile →
MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia

2006 1.0k citations Benjamin L. Ebert, Ross L. Levine et al. profile →
JAK2 Exon 12 Mutations in Polycythemia Vera and Idiopathic Erythrocytosis

2007 898 citations Ross L. Levine et al. profile →
MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients

2006 758 citations Ross L. Levine, David P. Steensma et al. Blood profile →
Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6

2015 609 citations Ross L. Levine et al. profile →
Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis

2012 577 citations Agnès Viale, Adriana Heguy et al. profile →
Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes

2017 521 citations Sean M. Devlin, David B. Solit et al. profile →
The role of mutations in epigenetic regulators in myeloid malignancies

2012 518 citations Alan H. Shih, Omar Abdel‐Wahab et al. profile →
Clonal Hematopoiesis and Evolution to Hematopoietic Malignancies

2018 305 citations Ross L. Levine et al. profile →
Acute myeloid leukaemia

2016 289 citations Ross L. Levine, Craig T. Jordan et al. profile →
Prophylactic and long-lasting efficacy of senolytic CAR T cells against age-related metabolic dysfunction

2024 104 citations Corina Amor, Yu-Jui Ho et al. Nature Aging profile →

Peers

Countries citing papers authored by Ross L. Levine

Since Specialization

Citations

This map shows the geographic impact of Ross L. Levine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ross L. Levine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ross L. Levine more than expected).

Fields of papers citing papers by Ross L. Levine

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ross L. Levine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ross L. Levine. The network helps show where Ross L. Levine may publish in the future.

Co-authorship network of co-authors of Ross L. Levine

This figure shows the co-authorship network connecting the top 25 collaborators of Ross L. Levine. A scholar is included among the top collaborators of Ross L. Levine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ross L. Levine. Ross L. Levine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development of a customizable mouse backbone spectral flow cytometry panel to delineate immune cell populations in normal and tumor tissues 2024 ·Frontiers in Immunology ·Ana Leda F. Longhini, (unknown), Margaret C. Kennedy, (unknown), (unknown), Wenbin Xiao, Scott W. Lowe, Ross L. Levine, Rui Gardner	4
2	Prophylactic and long-lasting efficacy of senolytic CAR T cells against age-related metabolic dysfunction breakdown → 2024 ·Nature Aging ·Corina Amor, (unknown), (unknown), Yu-Jui Ho, Sandeep Nadella, (unknown), Sebastian E. Carrasco, (unknown), Judith Feucht, Clemens Hinterleitner, Valentin J.A. Barthet, Jacob A. Boyer, Riccardo Mezzadra, (unknown), David A. Tuveson, Ross L. Levine, Lee W. Jones, Michel Sadelain, Scott W. Lowe	104
3	High-risk and silent clonal hematopoietic genotypes in patients with nonhematologic cancer 2023 ·Blood Advances ·Aaron J. Stonestrom, Kamal Menghrajani, Sean M. Devlin, Sebastià Franch‐Expósito, Ryan Ptashkin, (unknown), Barbara Spitzer, Xiaodi Wu, Justin Jee, (unknown), Jennifer H. Milbank, Ronak Shah, Abhinita Mohanty, A. Rose Brannon, Wenbin Xiao, Michael F. Berger, Simon Mantha, Ross L. Levine	5
4	Aire regulates chromatin looping by evicting CTCF from domain boundaries and favoring accumulation of cohesin on superenhancers 2021 ·Proceedings of the National Academy of Sciences ·Kushagra Bansal, Daniel A. Michelson, Ricardo N. Ramírez, Aaron D. Viny, Ross L. Levine, Christophe Benoıst, Diane Mathis	16
5	Therapeutic Efficacy of Combined JAK1/2, Pan-PIM, and CDK4/6 Inhibition in Myeloproliferative Neoplasms 2021 ·Clinical Cancer Research ·Raajit K. Rampal, Maria Pinzon-Ortiz, Amritha Varshini Hanasoge Somasundara, Benjamin H. Durham, Richard P. Koche, Barbara Spitzer, (unknown), (unknown), Bing Li, (unknown), Andriy Derkach, (unknown), (unknown), Tyler A. Longmire, (unknown), (unknown), (unknown), Gary Vanasse, Zhu Cao, Ross L. Levine	14
6	Therapeutic targeting of preleukemia cells in a mouse model of NPM1 mutant acute myeloid leukemia 2020 ·Science ·Hannah J. Uckelmann, (unknown), Eric Wong, Charlie Hatton, Hugh Giovinazzo, Jayant Y. Gadrey, Andrei V. Krivtsov, Frank G. Rücker, Konstanze Döhner, Gerard M. McGeehan, Ross L. Levine, Lars Bullinger, George S. Vassiliou, Scott A. Armstrong	152
7	Somatic Mutations Drive Specific, but Reversible, Epigenetic Heterogeneity States in AML 2020 ·Cancer Discovery ·Sheng Li, (unknown), Jiahui Wang, Cem Meydan, Jacob L. Glass, Alan H. Shih, Ruud Delwel, Ross L. Levine, Christopher E. Mason, Ari Melnick	24
8	Activation of JAK/STAT Signaling in Megakaryocytes Sustains Myeloproliferation In Vivo 2019 ·Clinical Cancer Research ·Brittany A. Woods, Wei Chen, Sophia Chiu, Christian Marinaccio, Chunling Fu, (unknown), Marinka Bulic, Qiong Yang, (unknown), Shengxian Jia, Praveen Suraneni, Kailin Xu, Ross L. Levine, John D. Crispino, Qiang Wen	46
9	Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in IDH2 - and TET2 -Mutant Acute Myeloid Leukemia 2017 ·Cancer Discovery ·Alan H. Shih, Cem Meydan, Kaitlyn Shank, Francine E. Garrett-Bakelman, Patrick S. Ward, Andrew M. Intlekofer, Abbas Nazir, Eytan M. Stein, Kristina M. Knapp, Jacob L. Glass, Jeremy Travins, (unknown), Camelia Gliser, Christopher E. Mason, Katharine Yen, Craig B. Thompson, Ari Melnick, Ross L. Levine	71
10	Enasidenib induces acute myeloid leukemia cell differentiation to promote clinical response 2017 ·Blood ·Michael Amatangelo, Lynn Quek, Alan H. Shih, Eytan M. Stein, Mikhail Roshal, Muriel D. David, Benoît Marteyn, Noushin Farnoud, Stéphane de Botton, Olivier Bernard, Bin Wu, Katharine Yen, Martin S. Tallman, Elli Papaemmanuil, Virginie Penard‐Lacronique, Anjan Thakurta, Paresh Vyas, Ross L. Levine	249
11	Targeting Cell Non-Autonomous MAPK Activation As a Novel Therapeutic Strategy in Myeloproliferative Neoplasms 2017 ·Bern Open Repository and Information System (University of Bern) ·Sara C. Meyer, (unknown), Simona Stivala, Anne Baerenwaldt, Hui Hao-Shen, Stefan Dirnhofer, Matthias S. Dettmer, Cédric Simillion, Sophia Chiu, Matthew D. Keller, Maria Kleppe, Morgane Hilpert, Andreas Buser, Jakob Passweg, (unknown), Radek C. Skoda, Ross L. Levine	4
12	Efficacy of ALK5 inhibition in myelofibrosis 2017 ·JCI Insight ·(unknown), Matthias Bartenstein, Wanke Zhao, Wan‐Ting Ho, Ying Han, (unknown), Adam W. Mailloux, Ling Zhang, Xuefeng Wang, (unknown), Kith Pradhan, Franck Rapaport, Huaquan Wang, Zonghong Shao, Xiubao Ren, Ulrich Steidl, Ross L. Levine, Zhizhuang Joe Zhao, Amit Verma, Pearlie K. Epling‐Burnette	34
13	Janus kinase inhibition lessens inflammation and ameliorates disease in murine models of hemophagocytic lymphohistiocytosis 2016 ·Blood ·Rupali Das, Peng Guan, Leslee Sprague, Katherine Verbist, Paige Tedrick, Qi An, Cheng Cheng, Makoto Kurachi, Ross L. Levine, E. John Wherry, Scott Canna, Edward M. Behrens, Kim E. Nichols	182
14	Genomics of primary chemoresistance and remission induction failure in paediatric and adult acute myeloid leukaemia 2016 ·British Journal of Haematology ·Fiona C. Brown, Paolo Cifani, Esther Drill, Jie He, Eric Still, Shan Zhong, Sohail Balasubramanian, (unknown), Bahar Yilmazel, Kristina M. Knapp, Todd A. Alonzo, Soheil Meshinchi, Richard M. Stone, Steven M. Kornblau, Guido Marcucci, Alan S. Gamis, John C. Byrd, Mithat Gönen, Ross L. Levine, Alex Kentsis	21
15	Defining ATM-Independent Functions of the Mre11 Complex with a Novel Mouse Model 2015 ·Molecular Cancer Research ·Alessia Balestrini, (unknown), (unknown), Olga A. Guryanova, Ross L. Levine, Craig H. Bassing, Jayanta Chaudhuri, John H.J. Petrini	7
16	Efficacy of Intermittent Combined RAF and MEK Inhibition in a Patient with Concurrent BRAF- and NRAS-Mutant Malignancies 2014 ·Cancer Discovery ·Omar Abdel‐Wahab, Virginia M. Klimek, (unknown), Agnès Viale, Donavan T. Cheng, Eun Hee Kim, Raajit K. Rampal, Mark J. Bluth, James J. Harding, Margaret K. Callahan, Taha Merghoub, Michael F. Berger, David B. Solit, Neal Rosen, Ross L. Levine, Paul B. Chapman	59
17	Selective Activity of the Histone Deacetylase Inhibitor AR-42 against Leukemia Stem Cells: A Novel Potential Strategy in Acute Myelogenous Leukemia 2014 ·Molecular Cancer Therapeutics ·Mónica L. Guzmán, Neng Yang, Krishan K. Sharma, Marlene Balys, Cheryl A. Corbett, Craig T. Jordan, Michael W. Becker, Ulrich Steidl, Omar Abdel‐Wahab, Ross L. Levine, Guido Marcucci, Gail J. Roboz, Duane C. Hassane	45
18	Validation of a Prognostic Model and the Impact of Mutations in Patients With Lower-Risk Myelodysplastic Syndromes 2012 ·Journal of Clinical Oncology ·Rafael Bejar, Kristen E. Stevenson, Bennett Adam Caughey, Omar Abdel‐Wahab, David P. Steensma, Naomi Galili, Azra Raza, Hagop M. Kantarjian, Ross L. Levine, Donna Neuberg, Guillermo Garcia‐Manero, Benjamin L. Ebert	312
19	Genetic Analysis of Transforming Events That Convert Chronic Myeloproliferative Neoplasms to Leukemias 2010 ·Cancer Research ·Omar Abdel‐Wahab, Taghi Manshouri, Jay Patel, Kelly L. Harris, JinJuan Yao, Cyrus V. Hedvat, Adriana Heguy, Carlos Bueso-Ramos, Hagop M. Kantarjian, Ross L. Levine, Srđan Verstovšek	227
20	Transcriptional Profiling of Polycythemia Vera Identifies Gene Expression Patterns Both Dependent and Independent from the Action of JAK2V617F 2010 ·Clinical Cancer Research ·Windy Berkofsky‐Fessler, Monica Buzzai, (unknown), Steven Fruchtman, Vesna Najfeld, (unknown), Fabrício F. Costa, Jared M. Bischof, Marcelo B. Soares, Melanie J. McConnell, Weijia Zhang, Ross L. Levine, D. Gary Gilliland, Raffaele Calogero, Jonathan D. Licht	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact